Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Nancy E. Messonier"'
Autor:
Desire Toboe, Clement Lingani, Stéphane Hugonnet, Nancy E. Messonier, Richard Mihigo, Denis Kandolo, Leonard W. Mayer, Patrick L.F. Zuber, William Perea, Mete Bonkoungou, F. Marc LaForce, Teresa Aguado, Nora Dellepiane de Rey Tolve, Carole Tevi-Benissan, Marie-Pierre Préziosi, Rodrigue Barry, Rene Sebgo, Mamoudou Harouna Djingarey, Fabien Diomandé, Dominique A. Caugant, Deo Nshimirimana, Monique Berlier, Thomas A. Clark, Sylvestre R. M. Tiendrebéogo, Ryan T. Novak, Paul A. Kristiansen
Publikováno v:
Vaccine. 30
A new Group A meningococcal (Men A) conjugate vaccine, MenAfriVac™, was prequalified by the World Health Organization (WHO) in June 2010. Because Burkina Faso has repeatedly suffered meningitis epidemics due to Group A Neisseria meningitidis specia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f015729a90ab8f0f6646334c861fd333
https://pubmed.ncbi.nlm.nih.gov/22607898
https://pubmed.ncbi.nlm.nih.gov/22607898
Publikováno v:
Vaccine. 27(SUPPL. 2)
Neisseria meningitidis is an important cause of bacterial meningitis and septicaemia with most disease caused by meningococci bearing serogroups A, B, C, Y and W-135 polysaccharides. Monovalent serogroup C conjugate vaccines have become established i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::219ae54f9157ff2bbb225292dcfd8dc3
http://ora.ox.ac.uk/objects/uuid:dc852561-40d8-4c9f-8e25-6bb8e144996f
http://ora.ox.ac.uk/objects/uuid:dc852561-40d8-4c9f-8e25-6bb8e144996f